264.89
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $264.89, with a volume of 228.28K.
It is up +1.16% in the last 24 hours and up +4.46% over the past month.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$261.77
Open:
$262.42
24h Volume:
228.28K
Relative Volume:
0.35
Market Cap:
$19.04B
Revenue:
$2.96B
Net Income/Loss:
$487.70M
P/E Ratio:
39.68
EPS:
6.6758
Net Cash Flow:
$344.00M
1W Performance:
-1.22%
1M Performance:
+4.46%
6M Performance:
+25.68%
1Y Performance:
-10.21%
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
WST
West Pharmaceutical Services Inc
|
264.84 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
![]()
ISRG
Intuitive Surgical Inc
|
437.49 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
188.01 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
273.68 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
72.83 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-15-25 | Initiated | Rothschild & Co Redburn | Buy |
Jun-24-25 | Initiated | Barclays | Equal Weight |
Mar-18-25 | Initiated | Evercore ISI | Outperform |
Feb-14-25 | Upgrade | Deutsche Bank | Hold → Buy |
Jan-08-25 | Initiated | Citigroup | Buy |
Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
Dec-12-24 | Upgrade | UBS | Neutral → Buy |
Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
Dec-14-22 | Initiated | Deutsche Bank | Hold |
Nov-30-22 | Initiated | UBS | Neutral |
Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
Oct-14-20 | Initiated | Stephens | Equal-Weight |
Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
May-01-19 | Downgrade | Jefferies | Buy → Hold |
Apr-23-19 | Initiated | William Blair | Outperform |
Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
Jan-24-18 | Initiated | Goldman | Neutral |
Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
Oct-03-17 | Initiated | Stephens | Equal-Weight |
Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
Mar-22-16 | Initiated | Wells Fargo | Outperform |
May-14-10 | Reiterated | UBS | Neutral |
Feb-23-10 | Initiated | Jefferies & Co | Buy |
Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
How to integrate West Pharmaceutical Services Inc. into portfolio analysis tools - newser.com
Vest Financial LLC Has $53.57 Million Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Can West Pharmaceutical Services Inc. stock surprise with quarterly resultsBear Alert & Community Trade Idea Sharing - newser.com
Published on: 2025-10-13 04:45:09 - newser.com
Why West Pharmaceutical Services Inc. stock could rally in 2025Weekly Investment Report & Safe Entry Point Identification - newser.com
Is West Pharmaceutical Services Inc. stock attractive after correctionQuarterly Profit Review & Technical Pattern Based Signals - newser.com
Sivik Global Healthcare LLC Purchases 2,500 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Grace & White Inc. NY Has $10.01 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Blair William & Co. IL Trims Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services (WST): Exploring Valuation as Analyst Confidence Grows Ahead of Q3 Earnings - Yahoo Finance
West Pharmaceutical Services Inc Stock Analysis and ForecastMACD Histogram Signals & High Profit Portfolio Growth - earlytimes.in
West Pharmaceutical Services’ Quarterly Earnings Preview: What You Need to Know - MSN
West to Host Third-Quarter 2025 Conference Call - The Malaysian Reserve
Real time social sentiment graph for West Pharmaceutical Services Inc.2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com
West to Host Third-Quarter 2025 Conference Call – Company Announcement - Financial Times
Will West Pharmaceutical Services Inc. stock keep high P E multiplesWeekly Trade Review & Real-Time Stock Movement Alerts - newser.com
West Pharmaceutical Services, Inc. (NYSE:WST) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
WEST PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
WEST PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into West Pharmaceutical Services, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
111 Capital Takes Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Robeco Institutional Asset Management B.V. Purchases 1,117 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Mirae Asset Global Investments Co. Ltd. Purchases 1,990 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
West Pharmaceutical (WST) Joins Evercore ISI's Tactical Outperfo - GuruFocus
West Pharmaceutical Services Forms Golden Cross, Signaling Bullish Breakout Ahead - Markets Mojo
Analyzing recovery setups for West Pharmaceutical Services Inc. investorsMarket Growth Report & Low Drawdown Momentum Trade Ideas - newser.com
Will West Pharmaceutical Services Inc. stock gain from lower interest rates2025 Market Outlook & Stepwise Entry and Exit Trade Signals - newser.com
Statistical indicators supporting West Pharmaceutical Services Inc.’s strengthTake Profit & Weekly High Conviction Trade Ideas - newser.com
What does recent volatility data suggest for West Pharmaceutical Services Inc.Quarterly Performance Summary & Daily Chart Pattern Signals - newser.com
Will West Pharmaceutical Services Inc. (WPS) stock beat growth indexesWeekly Stock Analysis & Smart Investment Allocation Insights - newser.com
Lecap Asset Management Ltd. Takes $324,000 Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Signaturefd LLC Has $161,000 Stock Holdings in West Pharmaceutical Services, Inc. $WST - Defense World
West Pharmaceutical Services, Inc. $WST Holdings Raised by Janney Montgomery Scott LLC - MarketBeat
State of Alaska Department of Revenue Sells 405 Shares of West Pharmaceutical Services, Inc. $WST - Defense World
Comparing West Pharmaceutical Services Inc. in custom built stock radars2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com
Farther Finance Advisors LLC Sells 103 Shares of West Pharmaceutical Services, Inc. $WST - Defense World
Price momentum metrics for West Pharmaceutical Services Inc. explained2025 Key Lessons & Consistent Growth Equity Picks - newser.com
Financial Comparison: West Pharmaceutical Services (NYSE:WST) vs. CONMED (NYSE:CNMD) - Defense World
Will West Pharmaceutical Services Inc. continue its uptrendEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
Barclays Maintains West Pharmaceutical Services (WST) Equal-Weight Recommendation - Nasdaq
What analysts say about West Pharmaceutical Services Inc WPS stockTechnical Pattern Recognition & Free Daily Top Stock Picks for All Investors - earlytimes.in
Barclays Adjusts Price Target on West Pharmaceutical Services to $275 From $260, Maintains Equalweight Rating - MarketScreener
West Pharmaceutical price target raised to $275 from $260 at Barclays - TipRanks
AMI Asset Management Corp Lowers Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Ninety One UK Ltd Cuts Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Public Employees Retirement System of Ohio Has $5.16 Million Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services to Announce Q1 2025 Results with Live Webcast and Q&A Session - MSN
3 Reasons to Avoid WST and 1 Stock to Buy Instead - The Globe and Mail
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
West Pharmaceutical Services Inc Stock (WST) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Reiss-Clark Cindy | Chief Commercial Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
5,131 |
MacKay Kimberly Banks | SVP, GC & Corporate Secretary |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
1,605 |
Favorite Annette F | Sr. VP & Chief HR Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
246 |
51,940 |
6,823 |
Winters Chad | VP, Chief Accounting Officer |
Feb 18 '25 |
Option Exercise |
211.00 |
82 |
17,313 |
1,391 |
Witherspoon Charles | VP & Treasurer |
Feb 18 '25 |
Option Exercise |
211.00 |
66 |
13,864 |
1,319 |
Green Eric Mark | President, CEO and Board Chair |
Feb 18 '25 |
Option Exercise |
211.00 |
2,461 |
519,269 |
170,369 |
Witherspoon Charles | VP & Treasurer |
Oct 29 '24 |
Option Exercise |
173.22 |
478 |
82,799 |
1,956 |
Witherspoon Charles | VP & Treasurer |
Oct 29 '24 |
Sale |
310.40 |
703 |
218,211 |
1,253 |
Abraham Silji | SVP, Chief Technology Officer |
Oct 29 '24 |
Option Exercise |
0.00 |
458 |
0 |
3,318 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):